Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study

PloS One
Oscar FernándezResearch Group Study EudraCT 2008-004015-35

Abstract

Currently available treatments for secondary progressive multiple sclerosis(SPMS) have limited efficacy and/or safety concerns. Adipose-mesenchymal derived stem cells(AdMSCs) represent a promising option and can be readily obtained using minimally invasive procedures. In this triple-blind, placebo-controlled study, cell samples were obtained from consenting patients by lipectomy and subsequently expanded. Patients were randomized to a single infusion of placebo, low-dose(1x106cells/kg) or high-dose(4x106cells/kg) autologous AdMSC product and followed for 12 months. Safety was monitored recording adverse events, laboratory parameters, vital signs and spirometry. Expanded disability status score (EDSS), magnetic-resonance-imaging, and other measures of possible treatment effects were also recorded. Thirty-four patients underwent lipectomy for AdMSCs collection, were randomized and thirty were infused (11 placebo, 10 low-dose and 9 high-dose); 4 randomized patients were not infused because of karyotype abnormalities in the cell product. Only one serious adverse event was observed in the treatment arms (urinary infection, considered not related to study treatment). No other safety parameters showed changes. Measures of treatment ef...Continue Reading

References

Dec 31, 2002·Lancet·Hans-Peter HartungUNKNOWN Mitoxantrone in Multiple Sclerosis Study Group (MIMS)
Dec 30, 2004·Neurology·Bruce A Cohen, Daniel D Mikol
May 15, 2007·Circulation Research·Jeffrey M GimbleBruce A Bunnell
Feb 22, 2008·Nature·Vincent F M Segers, Richard T Lee
Mar 8, 2008·Clinical Neurology and Neurosurgery·Shimon SlavinDimitrios Karussis
Oct 31, 2008·Lancet·Alastair Compston, Alasdair Coles
Jan 28, 2009·Nature Reviews. Immunology·Antonio UccelliVito Pistoia
Apr 28, 2009·Journal of Translational Medicine·Neil H RiordanBoris Minev
Nov 28, 2009·Current Stem Cell Research & Therapy·Paolo ErbaPaul J Kingham
Aug 24, 2010·Journal of Neuroimmunology·Bassem YamoutAli Bazarbachi
Oct 20, 2010·Current Stem Cell Research & Therapy·Natalie PayneClaude C A Bernard
Jan 6, 2012·BMC Medicine·Marios Politis, Olle Lindvall
Jan 13, 2012·Lancet Neurology·Mark S Freedman, Antonio Uccelli
Sep 7, 2012·Journal of Neurology, Neurosurgery, and Psychiatry·Loredana La MantiaGraziella Filippini
Sep 26, 2012·Nature Reviews. Neurology·Hans LassmannDon Mahad
Oct 16, 2012·Current Stem Cell Research & Therapy·Mandana Mohyeddin BonabMohammad Reza Gheini
Jan 17, 2013·Stem Cells and Development·Micaela Johanna Glat, Daniel Offen
Apr 25, 2014·Current Opinion in Neurology·Per Soelberg Sorensen
Apr 14, 2016·PloS One·Ahmed El-Badawy, Nagwa El-Badri
Dec 22, 2016·The New England Journal of Medicine·Xavier MontalbanUNKNOWN ORATORIO Clinical Investigators

❮ Previous
Next ❯

Citations

May 28, 2019·International Journal of Molecular Sciences·Loubna MaziniGabriel Malka
Jun 20, 2019·Expert Review of Neurotherapeutics·Laura E BaldassariJeffrey A Cohen
Sep 6, 2019·Pediatrics International : Official Journal of the Japan Pediatric Society·Fumihiko Namba
Mar 12, 2020·CNS Neuroscience & Therapeutics·Alison E WillingSubhra Mohapatra
Jun 4, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Jiandong PanHao Chen
Jan 16, 2019·Reviews in the Neurosciences·Tomasz Grzegorski, Jacek Losy
Jan 24, 2019·International Journal of Molecular Sciences·Ingo GerhauserAndreas Beineke
Mar 3, 2020·Frontiers in Bioengineering and Biotechnology·Abdelkrim HmadchaVivian Capilla-Gonzalez
Jul 11, 2018·Biochemical Society Transactions·Wei Seong TohSai Kiang Lim
Nov 21, 2018·Cell and Tissue Research·R A PoltavtsevaE V Svirshchevskaya
May 20, 2020·Journal of Translational Medicine·Christopher J RogersBoris R Minev
Mar 9, 2019·Brain Sciences·Jaroslav MichalekZuzana Dudasova
Oct 2, 2019·International Journal of Molecular Medicine·June Seok HeoJinkwan Kim
Aug 28, 2020·Frontiers in Bioengineering and Biotechnology·Enrique Mancha SánchezJ Blas Pagador
Sep 29, 2020·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·Fernando de la PortillaFabiola Lora
Dec 1, 2020·Brain : a Journal of Neurology·Panayiota PetrouDimitrios Karussis
Nov 26, 2019·Multiple Sclerosis and Related Disorders·Ana Gabriela OliveiraNuno M Neves
Nov 21, 2020·International Journal of Molecular Sciences·Agnese GugliandoloEmanuela Mazzon
Mar 20, 2021·Stem Cell Research & Therapy·Alexander MarkovAli Hassanzadeh
May 8, 2021·Cellular & Molecular Immunology·M J MansillaE M Martínez-Cáceres
May 8, 2021·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·Victoria Fernández
Jul 3, 2021·Biomolecules·Anna Trzyna, Agnieszka Banaś-Ząbczyk
Jul 25, 2021·International Journal of Molecular Sciences·Inez WensNathalie Cools
Jul 27, 2021·Frontiers in Cell and Developmental Biology·Jayden A SmithStefano Pluchino
Aug 12, 2021·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Elif TuncayNurdan Altan

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01056471

Software Mentioned

CABIMER

Related Concepts

Related Feeds

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.